University of Surrey

Test tubes in the lab Research in the ATI Dance Research

The symptom phenotype of oncology outpatients remains relatively stable from prior to through 1 week following chemotherapy.

Miaskowski, C, Cooper, BA, Aouizerat, B, Melisko, M, Chen, LM, Dunn, L, Hu, X, Kober, KM, Mastick, J, Levine, JD, Hammer, M, Wright, F, Harris, J, Armes, J, Furlong, E, Fox, P, Ream, E, Maguire, R and Kearney, N (2016) The symptom phenotype of oncology outpatients remains relatively stable from prior to through 1 week following chemotherapy. Eur J Cancer Care (Engl).

Full text not available from this repository.

Abstract

Some oncology outpatients experience a higher number of and more severe symptoms during chemotherapy (CTX). However, little is known about whether this high risk phenotype persists over time. Latent transition analysis (LTA) was used to examine the probability that patients remained in the same symptom class when assessed prior to the administration of and following their next dose of CTX. For the patients whose class membership remained consistent, differences in demographic and clinical characteristics, and quality of life (QOL) were evaluated. The Memorial Symptom Assessment Scale (MSAS) was used to evaluate symptom burden. LTA was used to identify subgroups of patients with distinct symptom experiences based on the occurrence of the MSAS symptoms. Of the 906 patients evaluated, 83.9% were classified in the same symptom occurrence class at both assessments. Of these 760 patients, 25.0% were classified as Low-Low, 44.1% as Moderate-Moderate and 30.9% as High-High. Compared to the Low-Low class, the other two classes were younger, more likely to be women and to report child care responsibilities, and had a lower functional status and a higher comorbidity scores. The two higher classes reported lower QOL scores. The use of LTA could assist clinicians to identify higher risk patients and initiate more aggressive interventions.

Item Type: Article
Authors :
NameEmailORCID
Miaskowski, CUNSPECIFIEDUNSPECIFIED
Cooper, BAUNSPECIFIEDUNSPECIFIED
Aouizerat, BUNSPECIFIEDUNSPECIFIED
Melisko, MUNSPECIFIEDUNSPECIFIED
Chen, LMUNSPECIFIEDUNSPECIFIED
Dunn, LUNSPECIFIEDUNSPECIFIED
Hu, XUNSPECIFIEDUNSPECIFIED
Kober, KMUNSPECIFIEDUNSPECIFIED
Mastick, JUNSPECIFIEDUNSPECIFIED
Levine, JDUNSPECIFIEDUNSPECIFIED
Hammer, MUNSPECIFIEDUNSPECIFIED
Wright, FUNSPECIFIEDUNSPECIFIED
Harris, JUNSPECIFIEDUNSPECIFIED
Armes, JUNSPECIFIEDUNSPECIFIED
Furlong, EUNSPECIFIEDUNSPECIFIED
Fox, PUNSPECIFIEDUNSPECIFIED
Ream, Ee.ream@surrey.ac.ukUNSPECIFIED
Maguire, Rr.maguire@surrey.ac.ukUNSPECIFIED
Kearney, NUNSPECIFIEDUNSPECIFIED
Date : 18 January 2016
Identification Number : https://doi.org/10.1111/ecc.12437
Uncontrolled Keywords : cancer, chemotherapy, latent transition analysis, predictive risk modelling, quality of life, symptoms
Related URLs :
Depositing User : Symplectic Elements
Date Deposited : 17 May 2017 10:43
Last Modified : 17 May 2017 14:52
URI: http://epubs.surrey.ac.uk/id/eprint/828965

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year


Information about this web site

© The University of Surrey, Guildford, Surrey, GU2 7XH, United Kingdom.
+44 (0)1483 300800